Altre lingue Compugen Ltd. TEL AVIV STOCK EXCHANGE

Azioni

CGEN

IL0010852080

Tempo differito TEL AVIV STOCK EXCHANGE Altri mercati azionari 11:00:34 09/05/2024			Variaz. 5gg	Var. 1 gen.
795,8 ^ILa	-1,97%		+4,71%	+15,67%

08/03	COMPUGEN LTD. : Truist Securities è per il Buy	ZM
05/03	Transcript : Compugen Ltd., Q4 2023 Earnings Call, Mar 05, 2024

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Compugen to Release First Quarter 2024 Results on Monday, May 20, 2024	06/05
Compugen to Present New Clinical Data Showing COM701 Triple Combination Preliminary Anti-Tumor Activity in Microsatellite Stable Colorectal Cancer with Liver Metastases at ASCO 2024	26/04
Compugen : To Present New Clinical Data Showing COM701 Triple Combination Preliminary Anti-Tumor Activity in Microsatellite Stable Colorectal Cancer with Liver Metastases at ASCO 2024	25/04
Compugen to Participate in Two Upcoming Investor Conferences	03/04
Compugen : Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapy	11/03
Compugen Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapy	11/03
Compugen to Present Data Reflecting its Diversified Immuno-Oncology Pipeline at AACR 2024	07/03
Compugen : To Present Data Reflecting its Diversified Immuno-Oncology Pipeline at AACR 2024	06/03
Compugen: Q4 Earnings Snapshot	05/03
Earnings Flash (CGEN) COMPUGEN Reports Q4 Revenue $33.5M	05/03
Earnings Flash (CGEN) COMPUGEN Posts Q4 EPS $0.11	05/03
Compugen : Form 6-K- Fourth quarter and full year 2023 results	05/03
Earnings Flash (CW9) COMPUGEN Posts Q4 EPS $0.11	05/03
Compugen Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	05/03
Compugen Reports Fourth Quarter and Full Year 2023 Results	05/03
Compugen to Present at the Leerink Partners Global Biopharma Conference 2024	26/02
Compugen to Release Fourth Quarter and Full Year 2023 Results on Tuesday, March 5, 2024	20/02
Compugen names new chief medical officer	16/02
Compugen Ltd. Announces Executive Changes	15/02
Compugen Announces Appointment of Michelle Mahler M.D. as Chief Medical Officer	15/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Compugen Ltd. TEL AVIV STOCK EXCHANGE

Azioni

CGEN

IL0010852080

Altre lingue

Filtri